Paperpal Prime Logo

Cancer Biomarkers : Impact Factor & More

eISSN: 1875-8592pISSN: 1574-0153

Key Metrics

CiteScore
7.3
H-Index
50
Impact Factor
< 5
SJR
Q2Genetics
SNIP
0.78
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Biomarkers

Cancer Biomarkers Journal Specifications

Overview
Publisher IOS PRESS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Cancer Biomarkers ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Biomarkers

A novel diagnostic model for early-stage high-grade serous ovarian cancer based on serum tRNA-derived fragments
  • 1 Jun 2026
  • Cancer Biomarkers: Section A of Disease Markers
Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and pancreatic neuroendocrine: A pilot study
  • 1 Jun 2026
  • Cancer Biomarkers: Section A of Disease Markers
Retraction notice: Glutamate dehydrogenase inhibits tumor growth in gastric cancer through the notch signaling pathway
  • 1 Jun 2026
  • Cancer Biomarkers: Section A of Disease Markers
The clinical assessment of miR-34a and miR-135b panel as promising diagnostic biomarkers predict the risk of colorectal cancer: A case-control study.
  • 1 Jun 2026
  • Cancer biomarkers : section A of Disease markers
Retraction Notice: Identification of GOLM1 as a positively regulator of tumor metastasis by regulating MMP13 in gastric carcinoma
  • 1 Jun 2026
  • Cancer Biomarkers: Section A of Disease Markers
Retraction notice: AnnexinA7 down-regulation might suppress the proliferation and metastasis of human hepatocellular carcinoma cells via MAPK/ ERK pathway.
  • 1 Jun 2026
  • Cancer biomarkers : section A of Disease markers
A novel diagnostic model for early-stage high-grade serous ovarian cancer based on serum tRNA-derived fragments
  • 1 Jun 2026
  • Cancer Biomarkers: Section A of Disease Markers
Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and pancreatic neuroendocrine: A pilot study
  • 1 Jun 2026
  • Cancer Biomarkers: Section A of Disease Markers
Retraction notice: Glutamate dehydrogenase inhibits tumor growth in gastric cancer through the notch signaling pathway
  • 1 Jun 2026
  • Cancer Biomarkers: Section A of Disease Markers
The clinical assessment of miR-34a and miR-135b panel as promising diagnostic biomarkers predict the risk of colorectal cancer: A case-control study.
  • 1 Jun 2026
  • Cancer biomarkers : section A of Disease markers
Retraction Notice: Identification of GOLM1 as a positively regulator of tumor metastasis by regulating MMP13 in gastric carcinoma
  • 1 Jun 2026
  • Cancer Biomarkers: Section A of Disease Markers
Retraction notice: AnnexinA7 down-regulation might suppress the proliferation and metastasis of human hepatocellular carcinoma cells via MAPK/ ERK pathway.
  • 1 Jun 2026
  • Cancer biomarkers : section A of Disease markers

FAQs on Cancer Biomarkers